2025-682-E-Health Dept-Pharmalink-Pharmaceutical drug return and destruction services

Browse Search

EXHIBIT A STATEMENT OF WORK Pharmaceutical Returns and Disposal Services – MMS2300885 This statement of work (“SOW”), adopts and incorporates by reference the terms and conditions of the Pharmaceutical Return and Disposal Service Agreement (“Agreement”) which was entered into on October 28, 2025 between PHARMALINK, INC, a Florida corporation, with its principal place of business located at 8285 Bryan Dairy Road, #200, Largo, FL 33777 ("PLI") and , with its principal place of business located at ("Customer" and together with PLI, the "Parties", and each a "Party"), as it may be amended from time to time. This SOW is effective beginning on (“Effective Date”) and will run commensurate with the term of the Agreement. Transactions performed under this SOW will be conducted in accordance with and be subject to the terms and conditions of this SOW and the Agreement. Capitalized terms used but not defined in this Statement of Work shall have the meanings set out in the Agreement. DEFINITIONS: "Authorized Distributor of Record" shall mean as defined in Section 503 (e)(3)(A) of the Federal Food, Drug and Cosmetic Act, a distributor with whom a Manufacturer has established an ongoing relationship to distribute such Manufacturer's Products. “Direct Credit” shall mean credit received by Customer, in the form of a check, from the Product Manufacturer or the Manufacturer’s Processor in lieu of credit issued to the Customer’s wholesaler account. “Estimated return Value” (ERV) shall mean the estimated credit value to be received from a manufacturer for a product that meets the manufacturers current Returned Good Policy (RGP). "Expired Product" shall mean returned prescriptions, damaged Product, Short Dated Products or Products that have exceeded the manufacturer’s shelf life date specified on the product’s packaging. "Manufacturer'' shall mean any company engaged in the production and sale of Products. “Product” shall mean brand pharmaceuticals, generic pharmaceuticals, specialty pharmaceuticals and over the counter products. “Product Value” (PV) shall mean ERV at the time the product is received and processed. “Pay by Credit” shall mean any amount due PLI, by the customer, shall be offset against the balance of the value of any present or future credits. "Non-scheduled Product" shall mean prescription pharmaceuticals which are not regulated by the Drug Enforcement Agency and not defined as a "Scheduled Product" under the Controlled Substance Act of 1970. "Scheduled Product" shall mean a drug or other substance, or immediate precursor, regulated by the Drug Enforcement Agency and defined under the Controlled Substance Act of 1970 including schedule I, II, Ill, IV and V products. “Short dated Product” shall mean Products that have a useful shelf life of less than six (6) months from the Product expiration date as noted on the Product package. Docusign Envelope ID: 550F0A34-DEE8-4FFA-B72D-1ABBE467C60B